ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | -98.8% | 182 | -99.2% | 0.00% | -100.0% |
| Q3 2019 | $848,000 | -22.6% | 21,466 | -19.5% | 0.01% | -25.0% |
| Q2 2019 | $1,096,000 | +69.4% | 26,679 | +91.9% | 0.01% | +60.0% |
| Q1 2019 | $647,000 | +247.8% | 13,902 | +226.6% | 0.01% | +150.0% |
| Q4 2018 | $186,000 | +402.7% | 4,256 | +554.8% | 0.00% | – |
| Q3 2018 | $37,000 | -96.5% | 650 | -97.0% | 0.00% | -100.0% |
| Q2 2018 | $1,060,000 | +40.4% | 21,848 | +13.1% | 0.02% | +50.0% |
| Q1 2018 | $755,000 | +25066.7% | 19,324 | +20678.5% | 0.01% | – |
| Q4 2017 | $3,000 | -95.4% | 93 | -94.6% | 0.00% | -100.0% |
| Q3 2017 | $65,000 | -74.3% | 1,709 | -79.5% | 0.00% | -75.0% |
| Q2 2017 | $253,000 | +14.5% | 8,319 | -0.4% | 0.00% | 0.0% |
| Q1 2017 | $221,000 | +127.8% | 8,354 | +119.7% | 0.00% | +100.0% |
| Q4 2016 | $97,000 | +59.0% | 3,803 | +123.4% | 0.00% | +100.0% |
| Q3 2016 | $61,000 | +1933.3% | 1,702 | +1250.8% | 0.00% | – |
| Q2 2016 | $3,000 | – | 126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |